Accumulation of fluconazole in scalp hair

R Yeates1, H Laufen, T Zimmermann

  • 1Department of Pharmacology, Pfizer Mack Development Centre, Illertissen, Germany.

Insights

Fluconazole accumulates in scalp hair, reaching concentrations higher than plasma during treatment. This antifungal drug remains detectable in hair for up to six months after therapy cessation.

Area of Science:

  • Pharmacokinetics
  • Dermatology
  • Mycology

Background:

  • Fluconazole is a widely used triazole antifungal agent.
  • Understanding drug accumulation in hair is crucial for assessing treatment efficacy and duration.
  • Scalp hair offers a matrix for long-term drug concentration monitoring.

Purpose of the Study:

  • To quantify fluconazole accumulation in human scalp hair during and after oral administration.
  • To compare fluconazole concentrations in hair with plasma levels.
  • To determine the persistence of fluconazole in hair post-treatment.

Main Methods:

  • Healthy subjects received daily oral fluconazole (50 mg) for 28 days or weekly (150 mg) for 4 weeks.
  • Fluconazole concentrations were measured in scalp hair sections and plasma at various time points.
  • Hair samples were analyzed using chromatography techniques.

Main Results:

  • Fluconazole concentrations in scalp hair increased during treatment and were consistently higher than plasma levels.
  • Mean hair-to-plasma concentration ratios reached up to 9.42.
  • Fluconazole was detectable in hair up to 6 months after treatment cessation in most subjects.

Conclusions:

  • Scalp hair effectively accumulates fluconazole, serving as a long-term reservoir.
  • Hair drug concentrations correlate with systemic exposure and treatment duration.
  • These findings support the use of hair analysis for monitoring fluconazole therapy.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...